Katie McManus's Colleagues at Trevi Therapeutics
Katie McManus's Contact Details
HQ
203-304-2499
203-304-2499
Location
Ireland
Ireland
Company
Trevi Therapeutics
Trevi Therapeutics
Katie McManus's Company Details
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.
Frequently Asked Questions about Katie McManus
Katie McManus currently works for Trevi Therapeutics.
Katie McManus's role at Trevi Therapeutics is Communications Coordinator.
Katie McManus's email address is ***@trevitherapeutics.com. To view Katie McManus's full email address, please signup to ConnectPlex.
Katie McManus works in the BioTech/Drugs industry.
Katie McManus's colleagues at Trevi Therapeutics are Lauren Waggoner Kriss, Lori Iwanicki, Lara Lewkowicz, Rebecca Morse, Jim Cassella, Anne VanLent, Farrell Simon and others.
Katie McManus's phone number is 203-304-2499